KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $5.5 billion.

  • Johnson & Johnson's Free Cash Flow rose 188.05% to $5.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $19.7 billion, marking a year-over-year decrease of 72.57%. This contributed to the annual value of $19.7 billion for FY2025, which is 72.57% down from last year.
  • As of Q4 2025, Johnson & Johnson's Free Cash Flow stood at $5.5 billion, which was up 188.05% from $8.0 billion recorded in Q3 2025.
  • In the past 5 years, Johnson & Johnson's Free Cash Flow ranged from a high of $8.0 billion in Q3 2025 and a low of $1.7 billion during Q1 2023
  • In the last 5 years, Johnson & Johnson's Free Cash Flow had a median value of $4.6 billion in 2021 and averaged $4.7 billion.
  • In the last 5 years, Johnson & Johnson's Free Cash Flow soared by 25974.77% in 2023 and then crashed by 3912.39% in 2025.
  • Johnson & Johnson's Free Cash Flow (Quarter) stood at $7.5 billion in 2021, then crashed by 55.3% to $3.4 billion in 2022, then surged by 86.06% to $6.3 billion in 2023, then fell by 14.39% to $5.4 billion in 2024, then increased by 1.88% to $5.5 billion in 2025.
  • Its Free Cash Flow was $5.5 billion in Q4 2025, compared to $8.0 billion in Q3 2025 and $2.8 billion in Q2 2025.